Benitec Biopharma Inc.
BNTC
$12.37
-$0.63-4.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | 0.00 |
| Gross Profit | -- | -- | -- | -- | 0.00 |
| SG&A Expenses | 34.74M | 36.30M | 34.17M | 29.95M | 18.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.94M | 55.69M | 53.12M | 49.11M | 37.48M |
| Operating Income | -53.94M | -55.69M | -53.12M | -49.11M | -37.48M |
| Income Before Tax | -48.88M | -51.45M | -49.17M | -45.26M | -33.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.88 | -51.45 | -49.17 | -45.26 | -33.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.88M | -51.45M | -49.17M | -45.26M | -33.83M |
| EBIT | -53.94M | -55.69M | -53.12M | -49.11M | -37.48M |
| EBITDA | -53.88M | -55.64M | -53.07M | -49.04M | -37.40M |
| EPS Basic | -1.11 | -1.24 | -1.24 | -1.21 | -1.00 |
| Normalized Basic EPS | -0.69 | -0.78 | -0.79 | -0.77 | -0.64 |
| EPS Diluted | -1.11 | -1.24 | -1.24 | -1.21 | -1.00 |
| Normalized Diluted EPS | -0.69 | -0.78 | -0.79 | -0.77 | -0.64 |
| Average Basic Shares Outstanding | 178.04M | 167.25M | 158.53M | 144.90M | 129.57M |
| Average Diluted Shares Outstanding | 178.04M | 167.25M | 158.53M | 144.90M | 129.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |